Consultative and Perioperative Medicine — MCQs
On this page
A hospital is implementing a protocol to reduce perioperative pulmonary complications in high-risk patients undergoing major abdominal surgery. Based on current evidence, which combination of interventions would provide the greatest benefit?
A 62-year-old man with drug-eluting stent placed 4 months ago requires urgent colonoscopy with polypectomy for a bleeding polyp. He is on dual antiplatelet therapy (aspirin and clopidogrel). Analysis of risks shows continued bleeding risk versus stent thrombosis risk. What is the most evidence-based management strategy?
A 72-year-old man develops postoperative delirium on day 2 after hip replacement. His vitals are stable, and examination is unremarkable except for confusion. Laboratory workup including CBC, electrolytes, and arterial blood gas is normal. What is the most likely precipitating factor?
A 45-year-old woman with Child-Pugh Class B cirrhosis requires urgent abdominal surgery. Preoperative labs show: Albumin 2.8 g/dL, Bilirubin 3.2 mg/dL, INR 1.9, Creatinine 1.1 mg/dL. Her MELD score is calculated as 18. What is the approximate 90-day mortality risk?
A 58-year-old diabetic patient on metformin is scheduled for CT scan with iodinated contrast. His serum creatinine is 1.8 mg/dL and eGFR is 42 mL/min/1.73m². What is the most appropriate management of metformin?
A 65-year-old man with mechanical aortic valve on warfarin (INR 2.8) requires elective cholecystectomy. What is the most appropriate perioperative anticoagulation management?
How does tranexamic acid reduce perioperative blood loss in major surgery?
Why is perioperative beta-blocker initiation not routinely recommended in patients undergoing non-cardiac surgery?
What is the minimum recommended duration to withhold aspirin before elective non-cardiac surgery in patients without coronary stents?
Which risk assessment tool is recommended by the American College of Cardiology/American Heart Association for preoperative cardiac evaluation?
Consultative and Perioperative Medicine Indian Medical PG Practice Questions and MCQs
Question 1: A hospital is implementing a protocol to reduce perioperative pulmonary complications in high-risk patients undergoing major abdominal surgery. Based on current evidence, which combination of interventions would provide the greatest benefit?
- A. Preoperative spirometry, postoperative incentive spirometry, early mobilization
- B. Smoking cessation >8 weeks prior, lung expansion maneuvers, epidural analgesia (Correct Answer)
- C. Prophylactic bronchodilators, routine chest physiotherapy, supplemental oxygen
- D. Preoperative antibiotics, deep breathing exercises, prolonged mechanical ventilation
Explanation: ***Smoking cessation >8 weeks prior, lung expansion maneuvers, epidural analgesia*** - **Smoking cessation** must occur at least **8 weeks** before surgery to effectively reduce the risk of pulmonary complications to baseline levels; shorter periods may actually increase secretion production [1]. - **Epidural analgesia** provides superior pain control for abdominal surgery, which facilitates better **respiratory effort** and prevents the diaphragm dysfunction that leads to atelectasis. *Preoperative spirometry, postoperative incentive spirometry, early mobilization* - While early mobilization is beneficial, **preoperative spirometry** is a diagnostic tool used for **risk stratification** rather than an intervention that actively reduces postoperative complications. - **Incentive spirometry** alone is generally not superior to deep breathing exercises and must be part of a broader lung expansion protocol to be effective. *Prophylactic bronchodilators, routine chest physiotherapy, supplemental oxygen* - **Prophylactic bronchodilators** are not recommended for all patients and should only be used in patients with specific underlying conditions like **COPD** or **Asthma** [1]. - **Routine chest physiotherapy** has not consistently demonstrated a significant reduction in **postoperative pulmonary complications (PPCs)** for general high-risk abdominal surgery patients. *Preoperative antibiotics, deep breathing exercises, prolonged mechanical ventilation* - **Prolonged mechanical ventilation** is actually a risk factor for **ventilator-associated pneumonia** and other lung injuries, rather than a preventive strategy [2]. - While **deep breathing exercises** are helpful, they are outweighed here by the risks associated with unnecessary mechanical ventilation and the lack of systemic evidence for routine **preoperative antibiotics** specifically for PPC prevention [3].
Question 2: A 62-year-old man with drug-eluting stent placed 4 months ago requires urgent colonoscopy with polypectomy for a bleeding polyp. He is on dual antiplatelet therapy (aspirin and clopidogrel). Analysis of risks shows continued bleeding risk versus stent thrombosis risk. What is the most evidence-based management strategy?
- A. Discontinue clopidogrel only, add prophylactic heparin bridging
- B. Discontinue both aspirin and clopidogrel 7 days before procedure
- C. Continue aspirin, discontinue clopidogrel 5 days before procedure (Correct Answer)
- D. Continue both aspirin and clopidogrel throughout procedure
Explanation: ***Continue aspirin, discontinue clopidogrel 5 days before procedure*** - In patients with a **coronary stent** implanted recently, maintaining **aspirin monotherapy** provides essential protection against **stent thrombosis** while reducing the procedural bleeding risk compared to dual therapy [1]. - For high-bleeding-risk procedures like **polypectomy**, guidelines recommend pausing **P2Y12 inhibitors** (clopidogrel) for **5 days** to allow platelet function to recover sufficiently. *Discontinue clopidogrel only, add prophylactic heparin bridging* - **Heparin bridging** is indicated for patients at high risk of **thromboembolism** (e.g., mechanical valves or AFib) but has no proven benefit in preventing **stent thrombosis**. - Utilizing heparin in place of antiplatelets increases **bleeding complications** without addressing the pathophysiology of platelet-induced stent occlusion. *Discontinue both aspirin and clopidogrel 7 days before procedure* - Complete cessation of **dual antiplatelet therapy (DAPT)** within the first 6-12 months of a **drug-eluting stent (DES)** severely increases the risk of **major adverse cardiovascular events (MACE)**. - Aspirin should almost always be continued perioperatively unless the procedure involves a closed-space surgery with a high risk of catastrophic bleeding, such as **neurosurgery**. *Continue both aspirin and clopidogrel throughout procedure* - While this strategy eliminates the risk of **stent thrombosis**, it significantly increases the risk of **post-polypectomy bleeding**, which can be difficult to manage during the procedure. - Current evidence-based surgical guidelines categorize **colonoscopic polypectomy** as a **high-bleeding-risk** procedure that mandates the temporary interruption of clopidogrel.
Question 3: A 72-year-old man develops postoperative delirium on day 2 after hip replacement. His vitals are stable, and examination is unremarkable except for confusion. Laboratory workup including CBC, electrolytes, and arterial blood gas is normal. What is the most likely precipitating factor?
- A. Undiagnosed dementia with acute decompensation
- B. Hypoxia from subclinical pulmonary embolism
- C. Multifactorial including surgery, medications, and environmental factors (Correct Answer)
- D. Occult infection not yet manifested
Explanation: Multifactorial including surgery, medications, and environmental factors - Postoperative **delirium** in elderly patients is most commonly triggered by a combination of **surgical stress**, **anesthesia**, and use of **opioid** or **anticholinergic** medications [1]. - The **unfamiliar environment** of the hospital, **sleep deprivation**, and **immobilization** post-surgery further exacerbate cognitive dysfunction in vulnerable individuals [1]. *Undiagnosed dementia with acute decompensation* - While **dementia** is a significant **predisposing factor** for delirium, it describes the baseline vulnerability rather than the acute trigger [1]. - In this clinical scenario, the delirium occurs on postoperative day 2, pointing toward the **perioperative stressors** as the primary precipitant [1]. *Hypoxia from subclinical pulmonary embolism* - A normal **arterial blood gas (ABG)** and stable vital signs effectively rule out **hypoxia** or significant **pulmonary embolism** as the cause [1]. - While PE is a concern after hip replacement, medical workup shows no **respiratory distress** or oxygenation issues to explain the confusion. *Occult infection not yet manifested* - The laboratory workup, including a normal **CBC**, makes an acute infectious process like **sepsis** or a **urinary tract infection** unlikely [1]. - While infection is a known cause of delirium, the absence of **fever**, **leukocytosis**, or vital sign instability directs the diagnosis toward non-infectious perioperative factors [1].
Question 4: A 45-year-old woman with Child-Pugh Class B cirrhosis requires urgent abdominal surgery. Preoperative labs show: Albumin 2.8 g/dL, Bilirubin 3.2 mg/dL, INR 1.9, Creatinine 1.1 mg/dL. Her MELD score is calculated as 18. What is the approximate 90-day mortality risk?
- A. 5-10%
- B. 40-50%
- C. 15-20%
- D. 25-30% (Correct Answer)
Explanation: ***25-30%*** - The **MELD score** (Model for End-Stage Liver Disease) is a validated predictor of **90-day mortality** in patients with cirrhosis undergoing major abdominal surgery [1]. - A **MELD score of 15-20** (this patient is 18) typically correlates with a post-operative mortality risk in the **25-30% range**. *5-10%* - This range is associated with **Child-Pugh Class A** or **MELD scores <10**, representing much lower perioperative risk. - Patients with such low scores have preserved **synthetic liver function** and minimal portal hypertension. *40-50%* - This elevated mortality risk is generally seen in patients with **MELD scores >20** or those with **Child-Pugh Class C** cirrhosis. - Surgical intervention in this group is often avoided unless it is life-saving due to the high risk of **liver failure** and **death** post-operatively. *15-20%* - This range often corresponds to patients with a **MELD score of 10-15** or compensated **Child-Pugh Class B** cirrhosis. - While the risk is significant, it is lower than the mortality predicted for a patient with a score of 18 and signs of **coagulopathy** (INR 1.9) [1].
Question 5: A 58-year-old diabetic patient on metformin is scheduled for CT scan with iodinated contrast. His serum creatinine is 1.8 mg/dL and eGFR is 42 mL/min/1.73m². What is the most appropriate management of metformin?
- A. Reduce metformin dose by 50% for 3 days
- B. Continue metformin and ensure adequate hydration
- C. Hold metformin on day of procedure, restart after 48 hours with normal renal function (Correct Answer)
- D. Stop metformin permanently and switch to insulin
Explanation: ***Hold metformin on day of procedure, restart after 48 hours with normal renal function*** - In patients with an **eGFR between 30-60 mL/min/1.73m²**, metformin must be withheld at the time of the procedure to mitigate the risk of **lactic acidosis** if contrast-induced nephropathy occurs. - Metformin should only be restarted **48 hours later** once serum creatinine has been re-evaluated and confirmed to be stable [1]. *Reduce metformin dose by 50% for 3 days* - Dose reduction is not the standard protocol; the drug must be **completely withheld** to prevent the accumulation of metformin in the setting of potential acute kidney injury. - This approach does not sufficiently protect the patient from the risk of **metformin-associated lactic acidosis (MALA)**. *Continue metformin and ensure adequate hydration* - While **hydration** is essential to prevent contrast-induced nephropathy, continuing metformin in a patient with an **eGFR <60** is contraindicated during radiocontrast administration. - Metformin is primarily **renally excreted**, and any transient decline in renal function could lead to dangerous systemic levels [1]. *Stop metformin permanently and switch to insulin* - **Permanent cessation** is unnecessary as the patient's eGFR (42 mL/min) is still above the absolute contraindication threshold for metformin (eGFR <30 mL/min) [2]. - Metformin remains a first-line therapy for Type 2 Diabetes; the interruption is only **temporary** to ensure safety during the peri-procedure period [2].
Question 6: A 65-year-old man with mechanical aortic valve on warfarin (INR 2.8) requires elective cholecystectomy. What is the most appropriate perioperative anticoagulation management?
- A. Stop warfarin 3 days before, bridge with unfractionated heparin infusion
- B. Continue warfarin throughout surgery
- C. Stop warfarin 5 days before, bridge with therapeutic LMWH (Correct Answer)
- D. Stop warfarin 5 days before, no bridging therapy
Explanation: Warfarin should be stopped **5 days preoperatively** to allow the INR to normalize, while **therapeutic-dose LMWH** is started once the INR drops below the therapeutic range [1]. *Stop warfarin 3 days before, bridge with unfractionated heparin infusion* - Stopping warfarin only **3 days before** surgery is often insufficient time for the **INR to reach <1.5**, increasing the risk of surgical bleeding [1]. - While **Unfractionated Heparin (UFH)** is an option, it requires hospitalization for IV administration, making **LMWH** the preferred choice for convenience in elective outpatient settings. *Continue warfarin throughout surgery* - Continuing warfarin is contraindicated for major abdominal surgeries like **cholecystectomy** due to the high risk of **intraoperative bleeding**. - This approach is typically reserved only for minor procedures with low bleeding risk, such as **minor dental or skin surgeries**. *Stop warfarin 5 days before, no bridging therapy* - Omitting bridging therapy is appropriate for low-risk patients, but this patient has a **mechanical heart valve**, which carries a high **thromboembolic risk**. - Failure to bridge in this population significantly increases the likelihood of **valvular thrombosis** or a **systemic embolic event** during the perioperative subtherapeutic window.
Question 7: How does tranexamic acid reduce perioperative blood loss in major surgery?
- A. By activating Factor VII
- B. By inhibiting plasminogen activation (Correct Answer)
- C. By promoting platelet aggregation
- D. By stabilizing fibrinogen
Explanation: ***By inhibiting plasminogen activation*** - **Tranexamic acid** is a synthetic derivative of the amino acid lysine that acts as a competitive inhibitor of **plasminogen activation**. - By binding to the lysine-binding sites on plasminogen, it prevents its conversion to **plasmin**, thereby inhibiting **fibrinolysis** and preserving the clot integrity. *By activating Factor VII* - Factor VII activation is part of the **extrinsic pathway** of the coagulation cascade; agents like **recombinant activated Factor VII (rFVIIa)** work via this mechanism, not tranexamic acid. - Supporting the coagulation cascade is distinct from inhibiting the breakdown of existing clots through **antifibrinolytics**. *By promoting platelet aggregation* - Platelet aggregation is primarily mediated by substances like **ADP**, **thromboxane A2**, and **von Willebrand factor**, rather than tranexamic acid. - While essential for **primary hemostasis**, tranexamic acid does not directly stimulate platelet receptors or aggregation pathways. *By stabilizing fibrinogen* - Fibrinogen is the precursor to fibrin; while tranexamic acid helps preserve the **fibrin mesh**, it does not chemically stabilize the fibrinogen molecule itself. - Stabilization of the **fibrin polymer** is typically the role of **Factor XIII**, which creates cross-links to strengthen the definitive clot.
Question 8: Why is perioperative beta-blocker initiation not routinely recommended in patients undergoing non-cardiac surgery?
- A. Lack of cardiovascular benefit
- B. Increased risk of stroke and mortality (Correct Answer)
- C. Poor patient compliance
- D. Increased risk of myocardial infarction
Explanation: Detailed clinical evidence, particularly from the POISE trial, suggests that the perioperative initiation of beta-blockers immediately before non-cardiac surgery increases risks such as stroke and all-cause mortality, though it provides some protection against myocardial infarction. Current management guidelines emphasize that while antihypertensive therapy aims to reduce adverse cardiovascular events like stroke and coronary artery disease [1], the specific safety profile in the perioperative setting requires caution due to potential hypotension and bradycardia; in certain critical contexts, such as heart failure or hypotension (systolic BP < 105 mmHg), beta-blockers should be avoided altogether [2]. ***Increased risk of stroke and mortality*** - Evidence from the **POISE trial** showed that starting **beta-blockers** immediately before non-cardiac surgery increases the risk of **stroke** and **all-cause mortality**. - This is likely due to perioperative **hypotension** and **bradycardia** which compromise cerebral perfusion during the surgical stress response. *Lack of cardiovascular benefit* - Beta-blockers actually provide a significant benefit by reducing the incidence of **perioperative myocardial infarction**. - The recommendation against routine initiation is based on the **safety profile**, not a lack of efficacy in protecting the heart. *Poor patient compliance* - Compliance is not the primary factor in **perioperative initiation**, as the medication is typically administered by clinical staff in a controlled setting. - The clinical guidelines are driven by **adverse outcomes** and data from randomized controlled trials rather than patient adherence issues. *Increased risk of myocardial infarction* - Perioperative beta-blocker initiation actually **decreases** the risk of **non-fatal myocardial infarction** by limiting tachycardia. - Despite this protective effect on the myocardium, the increased risks of **death and stroke** outweigh the benefit of preventing MI.
Question 9: What is the minimum recommended duration to withhold aspirin before elective non-cardiac surgery in patients without coronary stents?
- A. 10 days
- B. 3 days
- C. 5 days
- D. 7 days (Correct Answer)
Explanation: ***7 days*** - For elective **non-cardiac surgery** in patients without coronary stents, aspirin should be withheld for at least **7 days** to allow for the recovery of a sufficient population of **platelets** with normal function. - This timeframe is based on the **irreversible inhibition** of cyclooxygenase-1 (COX-1) and the approximately 10-day **lifespan of a platelet**, ensuring adequate hemostasis during the procedure. *10 days* - While 10 days covers the entire lifespan of a **platelet**, it is longer than the minimum clinical requirement for **adequate hemostasis** in most surgical cases. - Most guidelines prioritize a **7-day window** as balanced and sufficient for reducing **perioperative bleeding** risk. *3 days* - This duration is insufficient because only approximately **30% of platelets** would be replaced, leaving a significant risk of **antiplatelet-induced bleeding** during surgery. - **Incomplete recovery** of platelet function at 3 days can lead to complications in procedures requiring strict **hemostatic control**. *5 days* - While 5 days allows for some **platelet turnover**, it may not provide a safe margin for high-risk elective surgeries compared to the standard **7-day recommendation**. - Certain guidelines for other drugs like **warfarin** or **clopidogrel** may use this window, but for **aspirin**, 7 days remains the primary recommendation for total recovery.
Question 10: Which risk assessment tool is recommended by the American College of Cardiology/American Heart Association for preoperative cardiac evaluation?
- A. Goldman Cardiac Risk Index
- B. Gupta Myocardial Infarction or Cardiac Arrest Calculator
- C. Revised Cardiac Risk Index (RCRI) (Correct Answer)
- D. Detsky Modified Multifactorial Index
Explanation: ***Revised Cardiac Risk Index (RCRI)*** - The **RCRI** (or Lee's Index) is the standard tool recommended by the **ACC/AHA** guidelines to estimate the risk of **perioperative major adverse cardiac events (MACE)**. - It utilizes six independent predictors: **high-risk surgery**, ischemic heart disease, **congestive heart failure**, cerebrovascular disease, **insulin-dependent diabetes**, and serum creatinine >2.0 mg/dL. *Goldman Cardiac Risk Index* - This was the **original multifactorial clinical index** developed in 1977, but it has largely been replaced in modern practice by the updated RCRI. - It included factors like **S3 gallop** and **jugular venous distention**, which are more difficult to standardize than the criteria used in the RCRI. *Gupta Myocardial Infarction or Cardiac Arrest Calculator* - The **Gupta Calculator** (based on the NSQIP database) is a valid alternative but is not the primary clinical tool specifically emphasized in traditional **ACC/AHA preoperative guidelines**. - While it offers higher predictive accuracy for **perioperative MI**, it requires a web-based interface and includes **functional status** as a key variable. *Detsky Modified Multifactorial Index* - This index is a **modification of the Goldman Index** that includes variables like **angina class** and remote history of myocardial infarction. - It is utilized less frequently than the RCRI because it is more complex to calculate and has not shown superior **predictive value** in broad surgical populations.
Practice by Chapter
Preoperative Evaluation
Practice Questions
Risk Assessment and Stratification
Practice Questions
Perioperative Medication Management
Practice Questions
Cardiac Risk in Non-cardiac Surgery
Practice Questions
Pulmonary Risk Assessment
Practice Questions
Venous Thromboembolism Prophylaxis
Practice Questions
Postoperative Complications
Practice Questions
Perioperative Antibiotic Prophylaxis
Practice Questions
Special Population Considerations
Practice Questions
Perioperative Pain Management
Practice Questions
Postoperative Delirium Prevention
Practice Questions
Enhanced Recovery Protocols
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free